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Available online 31 May 2016Epigenetic changes, such as alteration of DNA methylation patterns, have been proposed as a molecular mecha-
nism underlying the effect of alcohol on the maintenance of adult stem cells. We have performed genome-wide
gene expression microarray and DNAmethylome analysis to identify molecular alterations via DNAmethylation
changes associatedwith exposure of human dental pulp stem cells (DPSCs) to ethanol (EtOH). By combined anal-
ysis of the gene expression and DNA methylation, we have found a signiﬁcant number of genes that are poten-
tially regulated by EtOH-induced DNA methylation. As a focused approach, we have also performed a
pathway-focused RT-PCR array analysis to examine potential molecular effects of EtOH on genes involved in epi-
genetic chromatin modiﬁcation enzymes, ﬁbroblastic markers, and stress and toxicity pathways in DPSCs. We
have identiﬁed and veriﬁed that lysine speciﬁc demethylase 6B (KDM6B) was signiﬁcantly dysregulated in
DPSCs upon EtOH exposure. EtOH treatment during odontogenic/osteogenic differentiation of DPSCs suppressed
the induction of KDM6Bwith alterations in the expression of differentiation markers. Knockdown of KDM6B re-
sulted in a marked decrease inmineralization from implanted DPSCs in vivo. Furthermore, an ectopic expression
of KDM6B in EtOH-treated DPSCs restored the expression of differentiation-related genes. Our study has demon-
strated that EtOH-induced inhibition of KDM6B plays a role in the dysregulation of odontogenic/osteogenic dif-
ferentiation in the DPSC model. This suggests a potential molecular mechanism for cellular insults of heavy
alcohol consumption that can lead to decreased mineral deposition potentially associated with abnormalities
in dental development and also osteopenia/osteoporosis, hallmark features of fetal alcohol spectrum disorders.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Mineralization1. Introduction
Heavy alcohol consumption could result in a range of health, social
and behavioral problems. Studies have demonstrated the potential
toxic effects of alcohol in many organs and have shown deleterious mo-
lecular effects on cellular physiology, including the potency andmainte-
nance of stem cells. Based on our previous study demonstrating the
epigenetic effect of alcohol on embryonic stem cell pluripotency22 CHS, Los Angeles, CA 90095,
r, American Dental Association
. This is an open access article under(Khalid et al., 2014a),we tested alcohol's epigenetic effect on the poten-
cy and differentiation capability of adult stem cells.
Alcohol consumption has been shown to have detrimental effects on
the brain, liver, muscles, skeleton and fetal development (Schuckit,
2009).While some studies have indicated that lowdoses of alcohol con-
sumption may increase bone mass and density (Feskanich et al., 1999;
Jugdaohsingh et al., 2006), chronic heavy alcohol use can dramatically
affect bone health and increase the risk of osteoporosis later in life. Dif-
ferent mechanisms have been hypothesized to cause changes related to
alcohol abuse, including a direct effect on osteoblasts and osteoclasts,
changes in signaling due to oxidative stress, increased fat accumulation
in the bone marrow, modulation of regulatory hormones, and/or indi-
rectly through decreased caloric intake (Sampson, 1997). The effects
of alcohol consumption on bone health are multifactorial and are relat-
ed to the duration and dosage of consumption (Maurel et al., 2012). Itthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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high incidences of dentofacial and temporomandibular joint disorders,
including midfacial underdevelopment with shortage of bone, delayed
dental development, enamel anomalies, and cleft palate or cleft lip
(Church et al., 1997). In an animalmodel,maternal alcohol ingestion be-
fore and during gestation caused retardation in cell differentiationwith-
in the tooth germ and in calciﬁcation of the dentin matrix (Sant'Anna et
al., 2005). The dental anomalies observed may stem from cellular alter-
ations in the basal layer of the epithelium of the tooth germ during
odontogenesis (Sant'Anna et al., 2005; Kieser, 1992; Jimenez-Farfan et
al., 2005a, 2005b).
Dental pulp stem cells (DPSCs), also known as dental pulp-derived
mesenchymal stem cells, are a multipotent adult stem cell population
that has a high proliferative potential. DPSCs in this study isolated
from adult teeth are easily accessible and cryopreservable for long pe-
riods (Papaccio et al., 2006; Laino et al., 2006). DPSCs were used as a
model of a mineralizing system, in vitro and in vivo, to study the effects
of EtOH. It has been shown in numerous studies that under various con-
ditions, dental pulp stem cells can be induced toward odontogenic and
osteogenic lineages. One study demonstrated that vascular endothelial
growth factor (VEGF) gene could promote odontogenic differentiation
in DPSCs in vitro (Zhang et al., 2014) while another identiﬁed that
DPSCs undergo osteogenic differentiation through the NF-kB signaling
pathway (Wang et al., 2013). DPSCs had the ability to differentiate to-
ward both odontogenic and osteogenic lineages in the presence of a
carboxymethyl cellulose-hydroxyapatite hybrid hydrogel (Teti et al.,
2015). Furthermore, medium modiﬁcation with bone morphogenetic
protein 2 was shown to stimulate odontogenic differentiation and for-
mation of an osteo-dentin matrix (Atalayin et al., 2016). Although
DPSCs have long been studied for their regenerative capabilities in
both dentistry and orthopedics, the molecular mechanisms controlling
their stem cell potency have yet to be discovered.
It has been shown thatKDM6B, a lysine-speciﬁc demethylase, plays a
key role in osteogenic differentiation by removing H3K27me3 from the
promoters of osteogenic genes in human bone marrow stromal cells
(BMSCs) (Ye et al., 2012). It has also identiﬁed KDM6B in controlling
HOX expression through the removal of H3K27me3 in human BMSCs
(Ye et al., 2012). A recent study has shown KDM6B to play a critical
role in the epigenetic regulation of odontogenic differentiation in
humanDPSCs (Xu et al., 2013). In DPSCs,KDM6B knockdown studies re-
sulted in decreased alkaline phosphatase activity and Alizarin Red stain-
ing, and reduced expression levels of marker genes, including osterix
(OSX), osteocalcin (OCN), and osteopontin (OPN) (Xu et al., 2013). De-
creased levels of these markers and mineralization parallel effects ob-
served in postmenopausal osteoporotic patients, who exhibit
signiﬁcant reductions in the number of osteocytes and osteoblasts,
and demineralization of compact and cancellous bone (Pavel et al.,
2016). While DPSCs primarily differentiate to dentin and BMSCs differ-
entiate to bone, both dentin and bone formation share similar mineral-
ization matrix components. Using the DPSC model of mineralization
will give us insight on the molecular effects of EtOH on mineralization
matrix that is similar to the bone mineralization model of BMSCs. In
this study, we explore the epigenetic effects of alcohol on DPSCs and a
possible link between alcohol and mineralization through the dysregu-
lation of KDM6B.
2. Materials and methods
2.1. Culture of human DPSCs and EtOH treatment
Early passage DPSCs (P1–P2) that were isolated from adult teeth
(molars) were cultured in α-MEM supplemented with 10% fetal bovine
serum (v/v), 2 mM L-glutamine, 100 μM L-ascorbate-2-phosphate,
50 units/ml penicillin and 50 μg/ml streptomycin. Exponentially grow-
ing DPSCs were treated with different concentrations of EtOH diluted
from absolute EtOH (FW = 21.7 M). For acute exposure, cells werefed with media containing given concentrations of EtOH (20 or
50 mM) for 24 or 48 h. For chronic exposure, cells were intermittently
exposed to EtOH by one-day exposure and one-day withdrawal for up
to 2 weeks.
2.2. Transcriptomic analysis
Total RNAwas isolatedwith RNeasy kit (Qiagen, Carlsbad, CA). Sam-
ples were prepared in biological duplicates. An equal amount from each
sample was subjected to biotinylation using the BioArray High Yield
RNA Transcript Labeling System (Enzo Life Sciences, Farmingdale, NY,
USA). An equal amount of cRNA from each sample was labeled, puriﬁed
and fragmented by using the GeneChip Sample Cleanup Module
(Affymetrix, Santa Clara, CA, USA). Following themanufacturer's proto-
cols, the Human Genome U133 Plus 2.0 Array (Affymetrix, Santa Clara,
CA) was applied for gene expression analysis (UCLA Clinical Microarray
Core Facility).
2.3. Methyl-DNA immunoprecipitation and DNA methylation array
analysis
Methyl-DNA immunoprecipitation was performed according to a
previous standard protocol from our laboratory by using antibody
against 5-methylcytidine (Eurogentec, San Diego, CA) (Kim et al.,
2012). Methylation array analysis was performed according to a previ-
ous standard protocol from our laboratory (Kim et al., 2012). Genomic
proﬁling was performed by NimbleGen Systems (100718 HG18 CpG
Refseq Promoter MeDIP). 3 μg of sonicated total DNA as input and 4 μg
of DNA sample immunoprecipitated with anti-5-methylcytidine were
sent to the UCLA Clinical Microarray core for differential random label-
ing by priming with Cy3 or Cy5 and hybridization to arrays. From the
scaled log2 ratio data, a ﬁxed-length window (750 bp) was placed
around each consecutive probe, and the one-sided Kolmogorov–
Smirnov (KS) test was applied to determine whether the probes were
drawn from a signiﬁcantlymore positive distribution of intensity log ra-
tios than those in the rest of the array. The resulting score for each probe
was− log10 (p value) from thewindowed KS test around the probe and
was assigned as “p-value.” NimbleScan software (NimbleGen Systems)
detects peaks by searching for at least two probes above a p value min-
imum cutoff (− log10) of 2. Using a custom Unix code, we aligned “ratio
peak p-values” to humangenome18 (RefSeq.hg18) and created amatrix
ﬁle.
2.4. Bioinformatics analysis
The fastq ﬁles generated have been processed using GALAXY and
aligned to the human genome version 19 (hg19) (https://main.g2.bx.
psu.edu/). Further analysis was done using R and a bioconductor. After
alignment to the genome perl scripts were used to delineate regions
of interest on proximal and distal promoters using the reference se-
quence obtained from the UCSC genome browser (http://genome.ucsc.
edu/). Subsequently, these regions have been clustered by K-means
clustering using Gene Cluster 3.0 (http://bonsai.hgc.jp/~mdehoon/
software/cluster/). Clusters identiﬁed were visualized using
JavaTreeView (http://jtreeview.sourceforge.net/). Furthermore, data
has been collapsed and correlated to gene expression data within R.
2.5. Pathway focused RT-PCR array analysis
Total RNA was puriﬁed and the quality of RNA was determined by
using Agilent Bioanalyzer. The samples were processed for RT2 Proﬁler
PCR array analysis (SABiosciences, Valencia, CA). Three different path-
way speciﬁc arrays were used— epigenetic chromatin modiﬁcation en-
zyme array, stress and toxicity array, and ﬁbroblastic marker array.
These arrays also contain genomic DNA contamination control, positive
PCR controls, and RT controls. To ensure inter-well and intra-plate
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value for each well. Results (Ct values) were normalized against ﬁve in-
ternal controls (ex: Actin B, GAPDH, 18S rRNA, etc.). Results have been
analyzed by using the company's RT2 Proﬁler PCR Array Data Analysis
version 3.5 (SABiosciences, Valencia, CA).
2.6. Odontogenic/osteogenic differentiation of human DPSCs and EtOH
treatment
DPSCs were grown in mineralization-inducing media containing
100 μM ascorbic acid, 2 mM β-glycerophosphate and 50 nM dexameth-
asone. Exponentially growing DPSCs were treated with different con-
centrations of EtOH diluted from absolute EtOH (FW = 21.7 M). For
acute exposure, cells were fed with media containing given concentra-
tions of EtOH (20 or 50 mM) for 24 or 48 h. For chronic exposure, cells
were intermittently exposed to EtOH (one-day exposure and one-day
withdrawal) for up to 2 weeks.
2.7. Transduction of human DPSCs and EtOH treatment
GP2-293 cells were grown in DMEM containing 10% FBS and tran-
siently transfected with Lipofectamine 3000 (Thermo Fisher Scientiﬁc,
Waltham, MA) to produce retroviral MSCV-KDM6B. DPSCs were cul-
tured to 60% conﬂuency and stably transducedwith either control retro-
virus or retroviral MSCV-KDM6B to generate KDM6B expressing DPSCs.
Exponentially growing DPSCs were grown in mineralization-inducing
media as described above and treated with different concentrations of
EtOH diluted from absolute EtOH (FW = 21.7 M). Cells were fed with
differentiation media containing given concentrations of EtOH (50 or
100 mM) for an indicated period of time.
2.8. Quantitative RT-PCR analysis of differentiation markers
For validation of gene expression by quantitative RT-PCR analysis,
total RNA was ﬁrst subjected to DNase digestion with a Turbo DNA-
free kit (Life Technologies, Grand Island, NY). 2 μg of total RNA treated
with a Turbo DNA-free kit (Thermo Fisher Scientiﬁc, Waltham, MA)
was used to synthesize cDNA by using an iScript cDNA synthesis kit
(Bio-Rad, Hercules, CA) in 40 μl of a reaction mixture. The resulting
cDNA was diluted (mixed with H2O by 1:4) and 1.5 μl of diluted cDNA
was used per well (in 10 μl reaction volume) in a 384 well plate using
a LightCycler 480 SYBR Green I master mix (Roche Diagnostics, India-
napolis, IN). PCR was done with a speciﬁc set of primers (Supplemental
Table 1) at an annealing temperature of 60 °C.
2.9. Alkaline phosphatase and Alizarin Red staining
For alkaline phosphatase (ALP) staining, after induction, cells were
ﬁxed with 4% paraformaldehyde and incubated with a solution of
0.25% naphthol AS-BI phosphate and 0.75% Fast Blue BB (Sigma-Aldrich,
St. Louis, MO, USA) dissolved in 0.1 M Tris buffer (pH 9.3). ALP activity
assay was performed using an ALP kit according to the manufacturer's
protocol (Sigma-Aldrich, St. Louis, MO, USA) and normalized based on
protein concentrations. To detect mineralization potential, cells were
induced for 2–3 weeks, ﬁxed with 4% paraformaldehyde and stained
with 2% Alizarin Red (Sigma-Aldrich, St. Louis, MO, USA). To quantify
the calcium mineral deposition, Alizarin Red was destained with 10%
cetylpyridinium chloride in 10 mM sodium phosphate for 30 min at
room temperature.
2.10. Implantation of DPSCs into immunocompromised mice
6.0 × 106 DPSCs were mixed with 40 mg of hydroxyapatite/
tricalcium phosphate (HA/TCP) ceramic powder (Zimmer Inc.) and
then implanted into the dorsal surface of 10-week-old immunocompro-
mised mice (Beige nude/nude Xid (III) mice) as previously described(Miura et al., 2004). The implants were harvested at 8 weeks post-im-
plantation, ﬁxed in 4% paraformaldehyde, and then decalciﬁed with
10% EDTA (pH 8.0) for parafﬁn embedding. Parafﬁn sections were
deparafﬁnized, rehydrated, and stained with hematoxylin and eosin
(H&E). Newmineralizedmatrix formationwas observed under amicro-
scope. For quantiﬁcation, the NIH software Image J was used as previ-
ously described (Miura et al., 2004).
3. Results
3.1. EtOH treatment resulted in signiﬁcant gene dysregulation and DNA
methylomic alterations in human DPSCs
To test our hypothesis that alcohol may have deleterious molecular
effects on the maintenance and regulation of adult stem cells, we have
used multipotent dental pulp stem cells (DPSCs) and acutely exposed
them (24 or 48 h) to a deﬁned concentration of EtOH (20 or 50 mM).
Cell growth analysis showed that 20 or 50 mM EtOH treatment did
not induce a signiﬁcant reduction in cell growth (Supplemental Fig. 1).
To proﬁle molecular signatures that are affected by EtOH treatment in
DPSCs, we have performed gene expression microarray analysis on
DPSCs after 24 h EtOH treatment. A genome-wide microarray
(Affymetrix Human Genome U133 Plus 2.0 Array platform) was used
on biological duplicates to generate gene expression data for DPSCs in
order to compare the concentration-dependent effects of EtOH (0, 20
or 50 mM) (GEO Accession: GSE57255). Weighted gene correlation
analysis (WGCNA) identiﬁed several genemodules that are signiﬁcantly
correlated to EtOH treatment and revealed a certain level of complexity
in gene expression level changes in response to EtOH treatment (Fig.
1A). We identiﬁed modules with dose-dependent changes in gene ex-
pression upon EtOH treatment (Fig. 1B). Also there were modules that
showed changes only speciﬁc to certain EtOH concentrations. We ob-
served differential molecular effects by different concentrations of
EtOH, such as when 20 mM EtOH showed different patterns of expres-
sion changes compared to 50mMEtOH. This implies that EtOH at differ-
ent concentration levels may have different physiological impacts
through differential molecular responses. Recently, epigenetic effects,
such as DNAmethylation, of alcohol on gene regulation have been doc-
umented (Khalid et al., 2014a, 2014b). To test our hypothesis that alco-
hol induces epigenetic alterations and leads to deregulation of gene
signatures in DPSCs, we have proﬁled DNA methylomic changes in
DPSCs that are potentially affected by EtOH exposure. We have per-
formed CpG Promoter microarray analysis coupled with methylated
DNA immunoprecipitation (MeDIP) on the same set of samples used
for transcriptomic proﬁling. The blue module consists of genes whose
promoters are hypermethylatedwith EtOH treatment and the turquoise
module represents genes whose promoters are hypomethylated upon
EtOH exposure (Fig. 1C). Heatmaps show changes in DNA methylation
in biological duplicates of DPSCs upon exposure to different concentra-
tions of EtOH (0, 20 and 50 mM) for 24 h. We have examined potential
effects of EtOH-mediated DNA methylomic changes on actual
transcriptomic alterations. We have performed combinatory analysis
on genes that were (1) hypermethylated with genes that were down-
regulated and (2) hypomethylated with genes that were upregulated
(Fig. 1D). We have identiﬁed genes that show concordant changes in
promoter methylation and gene expression. With 20 mM EtOH treat-
ment, we found that 434 genes were hypermethylated on the promoter
whose expressions were downregulated. We also found 469 genes that
were hypomethylated and upregulated. The results suggest that the
molecular repertoire of gene expression in DPSCs is widely affected by
EtOH-mediated DNA methylomic alterations.
Since we were interested in more physiologically relevant effects of
EtOH, we focused on 20 mM EtOH's effect that is known to be the DUI
level of alcohol in blood (Fig. 2A). We identiﬁed two gene modules
that were most signiﬁcantly associated with EtOH treatment — the
blue module for genes upregulated with EtOH exposure and the black
Fig. 1. Transcriptome analysis by gene expression microarray. A. Weighted gene co-expression network analysis (WGCNA) was performed to identify transcriptomic changes in DPSCs
induced by EtOH. Expression microarray data was processed by WGCNA and modules of genes that are correlated together were identiﬁed. Modules are clusters of highly
interconnected genes. In an unsigned co-expression network, modules correspond to clusters of genes with high absolute correlations. In a signed network, modules correspond to
positively correlated genes. A group of genes (module) correlated to Control (cor. Control without EtOH treatment), EtOH 20 mM (cor. EtOH 20 mM) or EtOH 50 mM (cor. EtOH
50 mM) was depicted by different colors (module colors). B. Intramolecular connectivity measures how connected, or co-expressed, a given gene is with respect to the genes of a
particular module. The intramolecular connectivity is interpreted as a measure of module membership: module–trait relationship map of all modules identiﬁed from analysis
demonstrating speciﬁc EtOH concentration-dependent, EtOH treatment-dependent, or EtOH dosage-dependent gene association modules. C. WGCNA analysis on DNA methylomic
changes to identify modules associated with EtOH treatment and epigenetically regulated by EtOH-induced DNA methylation in DPSCs. Most signiﬁcant modules were selected from
the module–trait detection and corresponding heat-maps (blue and turquoise modules) are shown. D. Venn diagram analysis of transcriptome vs. DNA methylation displays the
number of epigenetically regulated genes. Dosage-dependent hypermethylation and correlated decrease in gene expression due to EtOH. Dosage-dependent hypomethylation and
correlated increase in gene expression due to EtOH.
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amine the potential effects of EtOH on the biological process, we have
performed DAVID (The Database for Annotation, Visualization and Inte-
grated Discovery) on genes from the blue and black modules. The blue
module of upregulated genes upon EtOH treatment was associated
with several important signaling pathways, such as MAPK, calcium,
WNTandmTOR signaling (Fig. 2C). On the other hand, the blackmodule
of downregulated genes showed association with cell cycle, axon guid-
ance, neurotrophin signaling, TGF-beta signaling and p53 signaling (Fig.
2C). To examine if there is any concordance in molecular networks af-
fected by EtOH treatment, we have performed basic expression analysis
in Cytoscape.We established the core gene interaction network by com-
bining the genes in the blue or the black module with the network data
(Supplemental Fig. 2). The blue module contains CTBP1, FAM82A1
(RMD4), CCDC149, MYO10, FCGR2C, SRGAP2, DLGAP1, PPP2R5C and
CGLF2. The black module consists of STAG2, CCT2, PKG1,MAGIX, PDZD3,HNRNPD, INSIG1, FCRL5, HLA-E and PDLIM5. We have ranked genes
based on fold changes (N2-fold) and p values (b0.05) for each EtOH
concentration treatment (20 mM or 50 mM) for further selection and
validation (Table 1).
3.2. EtOH treatment triggered changes in epigenetic modiﬁers in human
DPSCs
To examine EtOH-induced changes in known epigeneticmodiﬁers in
DPSCs we have performed a pathway focused RT-PCR analysis and
assessed the effect of EtOH on the levels of known epigenetic chromatin
modiﬁcation enzymes, ﬁbroblastic markers, and stress/toxicity genes
(Qiagen Inc., Valencia, CA).We have used two different EtOH concentra-
tions (20 and 50mM) and treated cells acutely for 24 h. Heatmaps show
the level of genes upon exposure to EtOH relative to non-treatment con-
trol (Fig. 3). We observed both EtOH concentration-dependent and
Fig. 2.WGCNA on DPSCs treated with 20 mM EtOH. A. WGCNA for transcriptomic changes induced by 20 mM EtOH treatment that is comparable to a 0.08% blood alcohol concentration
(BAC) of the DUI level, leads to EtOH-induced gene expression changes inDPSCs. B.Module–trait relationshipmap andheatmap analysis of the black and bluemodules, or gene expression
proﬁles, where red indicates up-regulation and green indicates down-regulation. C. The Database for Annotation, Visualization and Integrated Discovery (DAVID) gene functional analysis
on the blue and the black module.
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ther attempted to validate the acute changes in gene expression, espe-
cially of epigenetic chromatin modiﬁcation enzymes, by quantitative
PCR analysis (Fig. 3D). Among 15 genes we tested (AURKA, DOT1L,
ESCO2, KAT2B, KAT7, KDM6B, MLL, NSD1, PRMT6, SETD1B, SETD7,
SUV39H1, FCHO, PRMT7, DNMT1, HDAC4 and HDAC11), we found that 8
genes showed the levels of expression concordant between the array re-
sult and qRT-PCR result.We found that lysine demethylase 6B (KDM6B)
showed the most noticeable change upon EtOH treatment (2.5-fold
downregulated in the RT array analysis and 4.6-fold downregulated in
the qRT-PCR analysis) (Fig. 3D). Previously KDM6B has been demon-
strated to play a role in the control of DPSC and BMSC (Ye et al., 2012;
Xu et al., 2013), which suggests that alcohol-mediated dysregulation
of KDM6B may have a functional link to the effect of alcohol exposure
on osteogenic differentiation of DPSCs.
3.3. EtOH treatment induced dysregulation of KDM6B and odontogenic/
osteogenic differentiation
To examine if EtOH treatment has any functional effect on the min-
eralization of DPSCs, we have cultured DPSCs under odontogenic/osteo-
genic differentiation conditions and examined the molecular effect ofEtOH on the expression of differentiation-related lineage markers
(Fig. 4). It has been previously demonstrated that the induction of
KDM6B during odontogenic differentiation is immediate. Since KDM6B
was previously demonstrated as an early responder (Xu et al., 2013),
the fold changes of KDM6B expression with and without induction of
differentiation treatment at 20 mM EtOH were analyzed at the 2 h
time point (Fig. 4A). Upon analysis, EtOH treatment resulted in a signiﬁ-
cant reduction of KDM6B expression level during odontogenic/osteogenic
differentiation (2.5-fold downregulated in the qRT-PCR analysis). Fur-
thermore, relative expression levels of the mineralization-associated
markers we tested (ALP, BMP2, BMP4, DLX2, OCN, and OPN) at the 24
and 72 h time periods all exhibited concentration dependent reductions
to EtOH, with more signiﬁcant decreases at the 72 h time point
(Fig. 4B). As KDM6B has been demonstrated to play an early role in the
control ofDPSC fate,we suggest that thesedifferentiation-relatedmarkers
may be functioning downstream of the epigenetic modiﬁer.
Following the analysis of the acute effects of EtOH in DPSCs, we
investigated the chronic effects of EtOH onmineralization.We inves-
tigated these long-term effects on differentiation in vitro by culturing
DPSCs in odontogenic/osteogenic differentiation media for 2 weeks
with 20 mM or 50 mM level of EtOH treatment. The effects of EtOH
on mineralization were qualitatively visualized through Alizarin
Table 1
List of genes from DPSCs treated with 20 or 50 mM EtOH for 24 h (p b 0.05).
EtOH 20 mM EtOH 50 mM
Gene symbol Fold change Gene symbol Fold change Gene symbol Fold change Gene symbol Fold change
ELK4 4.4 DDR2 −3.2 ELK4 2.9 RPL10L −4.3
MGC24103 2.9 ITPRIPL2 −2.8 CALD1 2.9 MALAT1 −2.9
ZCCHC7 2.9 MALAT1 −2.7 SUZ12P 2.3 ATG3 −2.7
SPATS2L 2.8 TMPO −2.6 MCTP2 2.2 RBM5 −2.3
SPEN 2.7 ZYG11B −2.6 RASEF 2.1 SNX11 −2.3
SATB2 2.7 KDM6B −2.5 GUSBP3 2.0 SSFA2 −2.2
PPP1R9B 2.5 CALD1 −2.5 LRP1 2.0 LAMA3 −2.1
NCRNA00182 2.4 ZNF655 −2.5 COL12A1 2.0 METTL7A −2.1
CLCN5 2.3 C13orf37 −2.4 LRRC27 −2.1
LRP1 2.3 RPL37A −2.3 SLAIN2 −2.1
MCTP2 2.3 APOOL −2.2 MALAT1 −2.1
RNF167 2.2 LOC100288675 −2.2 SEC62 −2.1
RAB3B 2.2 PTPN11 −2.1 C11orf31 −2.0
KIAA0754 2.2 EIF5B −2.1 C13orf31 −2.0
QSER1 2.2 ATG3 −2.1 USP28 −2.0
MAP4K4 2.2 MALAT1 −2.1 DDR2 −2.0
NFAT5 2.2 KPNA5 −2.1 LARP4 −2.0
LOC286272 2.1 DHFR −2.0
ANKRD28 2.1 WSB1 −2.0
LOC100289230 2.1 C6orf62 −2.0
RALGPS2 2.1 N4BP2L2 −2.0
RANBP2 2.1 ESCO1 −2.0
ITGA8 2.1 EHBP1L1 −2.0
PIK3C2A 2.0 PTPRO −2.0
MYCBP2 2.0 ERCC8 −2.0
LOC572558 2.0 GNG12 −2.0
LRCH3 2.0
PARVA 2.0
CD44 2.0
Fig. 3. Pathway focusedRT-PCR array analysis for genes affected inDPSCs by EtOH treatment. For acute exposure DPSCswere treated for 24 hwith 20 or 50mMEtOH. For chronic exposure
cellswere treated every other day for 10 dayswith 20 or 50mMEtOH. Total RNAwaspreparedand subjected to RT-PCRarray analysis. A. Fibroblasticmarker array. B. Epigenetic chromatin
modiﬁcation enzymes array. C. Stress and toxicity pathwayﬁnder array. Datawas analyzed and fold changes against no treatment are presented. D. Quantitative RT-PCR analysiswas done
to validate the result from the epigenetic modiﬁer RT array. Error bar shows the standard error margin (SEM).
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Fig. 4. Effect of EtOHonmolecular regulation of odontogenic/osteogenic differentiation. A. Comparison of the fold changes of KDM6B expressionwith andwithout odontogenic/osteogenic
differentiation treatment in DPSCs. In response to EtOH, KDM6B expression is signiﬁcantly reduced during differentiation. Error bar shows the standard error margin (SEM). Statistical
signiﬁcance was determined by Student t-test (p b 0.05). B. Comparison of the relative expression levels of osteomarkers in DPSCs under differentiation with or without treatment
(20 mM or 50 mM EtOH) for 24 h and 72 h. At both 24 h and 72 h, reduced levels of various osteomarkers were observed. Statistical signiﬁcance was determined by the one-way
ANOVA (p b 0.05). Error bar shows the standard error margin (SEM). C. Disruptive effects of EtOH on mineralization in vitro. Reduced levels of mineralization assessed by Alizarin
staining were observed in response to EtOH.
117M. Hoang et al. / Stem Cell Research 17 (2016) 111–121Red staining. At the 2-week time point, Alizarin Red staining, indica-
tive of calcium accumulation by cells of an odontogenic/osteogenic
lineage, was highest in the control group differentiated without
EtOH treatment (Fig. 4C). As the concentration of EtOH treatment in-
creased from 20 mM to 50 mM, a progressive level of the decreased
staining was observed. Similarly, alkaline phosphatase staining wasFig. 5.Knockdownof KDM6B resulted in a reducedmineralization potential in vivo. A. DPSCswe
Waltham, MA). Quantitative RT-PCR analysis showed N2-fold reduction in KDM6B in siKDM
determined by Student t-test (*: p b 0.05). B. DPSCs transfected with control (scrambled siR
Formation of mineralized tissue (M) and connective tissue (CT) around HA/TCP (HA) is in
resulted in about 66% reduction in bone area compared to the control. Statistical signiﬁcan
margin (SEM).highest in the control group differentiated without EtOH treatment
(data not shown). Much like the results observed with the Alizarin
Red staining, the density of the staining progressively decreased
with increasing concentrations of EtOH at 20 mM and 50 mM.
These results suggest that EtOH has both acute and chronic effects
on the mineralization potential of DPSCs.re transiently transfectedwith a scrambled siRNA or siKDM6B construct (Thermo Scientiﬁc,
6B cells. Error bar shows the standard error margin (SEM). Statistical signiﬁcance was
NA) or siKDM6B cells were implanted into mice as described in Materials and methods.
dicated in the H&E staining section. Quantitative measurement showed that siKDM6B
ce was determined by Student t-test (**: p b 0.05). Error bar shows the standard error
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DPSCs
Our ﬁndings support that EOH treatment resulted in suppression of
KDM6B alongwith inhibition ofmineralization in DPSCs.We next inves-
tigated whether the expression level of KDM6Bwas directly correlated
with odontogenic/osteogenic differentiation potential through associat-
ed osteomarkers. It has recently been demonstrated that a knockdown
of KDM6B in BMSCs and DPSCs resulted in dysregulation of osteogenic
and odontogenic differentiation in vitro and in vivo (Ye et al., 2012; Xu
et al., 2013). As KDM6Bwas signiﬁcantly related to the odontogenic/os-
teogenic potential of DPSCs in vitro, we performed an in vivo study in
mice to further investigate KDM6B ability to induce mineralization.
DPSCs in the control group were transfected with non-targeting siRNA
while the experimental group was transfected with siKDM6B (Fig. 5A).
Subsequently, these cells were implanted into immunocompromised
mice and allowed to differentiate. Following an8-week time period, his-
tological analysis of the H&E staining in the control group indicated the
formation of mineralized tissue and minimal connective tissue around
tricalcium phosphate/hydroxyapatite (TCP-HA) bone scaffold (Fig. 5B).
In contrast, DPSCs transfected with siKDM6B showed signiﬁcant reduc-
tions in the formation ofmineralized tissue andmore prominent forma-
tion of connective tissue. When a quantitative analysis of the total in
vivo mineralized matrix area was performed, the DPSCs transfected
with siKDM6B showed a 66% reduction in mineral deposition as com-
pared to the control (Fig. 5C). Our results suggest that KDM6B is neces-
sary for odontogenic/osteogenic differentiation potential and formation
of mineralized tissue.3.5. Ectopic expression of KDM6B restored odontogenic/osteogenic
differentiation in EtOH-treated DPSCs
To further assess the direct functional signiﬁcance of EtOH-induced
suppression of KDM6B in the effect of alcohol exposure on
odontogenic/osteogenic differentiation, we examined the restorative
effect of the ectopic expression of KDM6B on EtOH-induced dysregula-
tion of mineralization. DPSCs in culture were stably transduced with
retroviral KDM6B expression construct and control virus. The expres-
sion of transduced KDM6B was determined by qRT-PCR and Western
analysis (Fig. 6A). In addition, the transduced cells were subjected to
odontogenic/osteogenic differentiation for 2 weeks. We analyzed the
odontogenic/osteogenic differentiation potential of transduced DPSCs
through the expression of alkaline phosphatase (ALP), which is fre-
quently used to characterize the activity of mineralizing cells (Benoit
et al., 2006; Chen et al., 2007; George et al., 2006; Roostaeian et al.,
2006; Zhang et al., 2006). Following ALP staining, we found that
DPSCs transducedwith the control vector showed a signiﬁcant, progres-
sive reduction in ALP staining at 50 and 100 mM EtOH treatment. In
contrast, DPSCs transducedwith theMSCV-KDM6B construct and treat-
ed with 50 and 100 mM EtOH showed enhanced levels of staining as
compared to the control cells. Our results suggest that KDM6B was
able to adequately restoremineralization potential of DPSCs in the pres-
ence of varying levels of EtOH.
The resulting transduced cells were subjected to odontogenic/osteo-
genic differentiation for 24 or 72 h and the level of osteogenic marker
expression was quantitatively assessed. It was found that the forced ex-
pression of KDM6B in differentiating DPSCs in the absence of EtOH
treatment caused alterations in mineralization-related genes (Fig. 6B).
Some of the markers (DLX2, DLX5, and IBSP) were further induced by
the expression of exogenous KDM6B compared to the control vector.
However, the expression ofOCN and SPPwere suppressed by the ectopic
expression of KDM6B. There were slight differences at the level of
changes between the 24 and 72 h differentiation, but the trend of the ef-
fect of KDM6B expression on marker gene expression was similar be-
tween the two time points.The effect of KDM6B expression on the EtOH-induced suppression of
odontogenic/osteogenic differentiation genes was determined. As
shown in Fig. 6C, the forced expression of KDM6B in DPSCs suppressed
EtOH-induced inhibition of mineralization in vitro. Compared to DPSCs
transduced with the control virus, KDM6B expressing DPSCs showed
signiﬁcant induction of differentiation-related genes even in the pres-
ence of either 50 or 100 mM EtOH (Fig. 6C). It was noted that the sup-
pressive effect of 50 mM EtOH treatment on gene expression was
more readily reversed by the expression of KDM6B than cells with
100 mM EtOH treatment (ALP, BMP2, BMP4, IBSP, DLX5 and OCN). The
DLX2 gene was least affected by KDM6B. A higher dose of EtOH
(100 mM compared to 50 mM) and a longer exposure (72 h compared
to 24 h) to EtOH resulted in a reduction of the effect of exogenous
KDM6B expression on the recovery of odontogenic/osteogenic gene
expression.
We found that the forced expression of KDM6B signiﬁcantly altered
the response of DPSCs to EtOH treatment. As shown in Fig. 6D, we found
that EtOH treatment induced the expression of mineralization-related
genes in KDM6B expressing cells. The expression of markers was signif-
icantly inhibited by 50mM EtOH treatment when comparedwithin the
control group (0mMEtOH) for genes ALP (p=0.04), BMP4 (p=0.003),
OCN (p b 0.0001), and SPP (p b 0.0001) (Fig. 6D). The ectopic expression
of KDM6B resulted in signiﬁcant increases in expression levels of these
genes when treated with EtOH (50 mM) compared to non-treated cells
(0 mM), particularly at 5.53 fold (p=0.003) and 4.94 fold (p b 0.0001)
increases for OCN and SPP, respectively. It seems that molecular dynam-
ics and timing in signaling between mineralization signals and the reg-
ulation of key regulators such as KDM6B is important to ensure proper
mineralization of DPSCs. A prolonged expression of KDM6B at a non-
physiological level as shown in KDM6B expression cells could cause
dysregulation in cellular response and downstreammolecular signaling
pathways. Overall, our results suggest that the expression of KDM6B in
DPSCs can counteract the effects of EtOH-induced inhibition of
odontogenic/osteogenic differentiation and promote mineralization in
the presence of EtOH.
4. Discussion
Alcohol abuse appears to lead to periodontal disease, tooth decay
and mouth sores that are potentially precancerous (Tezal et al., 2001;
Amaral Cda et al., 2008; Yusko et al., 2008; Park et al., 2014). Persons
who abuse alcohol are at high risk of having seriously deteriorated
teeth, gums and compromised oral health in general (Tezal et al.,
2001; Amaral Cda et al., 2008; Yusko et al., 2008; Park et al., 2014). It
is generally believed that alcohol may have toxic effects on various cel-
lular functions, but we lack detailed information about molecular and
cellular effects of alcohol on stem cell maintenance and the differentia-
tion process. Our recent publication demonstrated that EtOH exposure
induced signiﬁcant transcriptomic alterations in human embryonic
stem cells (hESCs) through DNA methylomic deregulation (Khalid et
al., 2014a). Several studies have demonstrated effects of EtOH on DNA
methylation, resulting in genetic and phenotypic changes (Pandey et
al., 2008; Oberlander et al., 2008; Shukla et al., 2008; Ouko et al.,
2009; Haycock, 2009; Liu et al., 2009; Moonat et al., 2010; Qiang et al.,
2010; Miranda et al., 2010; Kaminen-Ahola et al., 2010). It has been
shown that EtOH induced alterations in DNA methylation patterns
and inhibited neural stem cell (NSC) differentiation (Zhou et al.,
2011). EtOH induced the hypermethylation of multiple cell cycle
genes and increased the expression of DNA methyltransferases in
NSCs. These alterations affected growth factor signaling, in conjunction
with the down regulation of associated mRNAs and cell cycle proteins
(Hicks et al., 2010). In another study, EtOH exposure prevented the
methylation of speciﬁc genes related to neural development, including
insulin-like growth factor 1 (IGF1), epidermal growth factor-containing
ﬁbulin-like extracellular matrix protein (EFEMP1), and SRY-box-con-
taining gene 7 (SOX7) (Zhou et al., 2011). The hyper- or
Fig. 6. Expression of KDM6B restored differentiation potency in EtOH-treated DPSCs. A. DPSCs were transduced with retroviral KDM6B expression construct (MSCV-KDM6B) or control
virus. Three days after transduction cells were lysed and total RNA or protein was puriﬁed. The expression of transduced KDM6B was monitored by qRT-PCR or Western analysis using
anti-KDM6B (1:1000, OriGene Technologies, Inc., Rockville, MD). For protein loading control anti-actin antibody (1:3000, Sigma, St. Louis, MO) was used. Transduced DPSC cells were
plated into 24 well plates and treated with mineralization media containing 0, 50 or 100 mM EtOH for 2 weeks with daily medium change. Differentiation of DPSCs was monitored by
alkaline phosphatase staining. B. The effect of overexpressing KDM6B in DPSCs on the expression of differentiation-related genes was examined. DPSCs transduced with either control
or MSCV-KDM6B were differentiated in osteogenic media for 24 or 72 h and the level of differentiation-related genes was assessed by qRT-PCR in triplicates. Ectopic expression of
KDM6B resulted in a differential regulation of lineage marker genes. For both 24 and 72 h differentiation, DLX2, DLX5 and IBSP were consistently induced by KDM6B, but OCN and SPP
were consistently suppressed. Statistical signiﬁcance was determined by one-way ANOVA and p value b 0.05 is considered as signiﬁcant (with asterisk). Error bar shows the standard
error margin (SEM). C. Transduced cells were plated into 6 well plates and N90% conﬂuent cells were treated with odontogenic/osteogenic differentiation media containing 50 or
100 mM EtOH for 24 and 72 h. Total RNA was isolated and qRT-PCR analysis was performed for various osteogenic marker genes. Comparison was made within samples for control
cells and KDM6B expressing cells by determining the relative fold change for 50 or 100 mM EtOH treatment. Statistical analysis was done on triplicate samples using the one-way
ANOVA and p value b 0.05 is considered as signiﬁcant (with asterisk). Error bar shows the standard error margin (SEM). D. The effect of EtOH treatment on mineralization-associated
gene expression was compared between DPSCs transduced with the control virus and overexpressing KDM6B. DPSCs transduced with either the control virus or MSCV-KDM6B were
differentiated for 24 h in the presence of 0 or 50 mM EtOH. The levels of mineralization-associated genes were determined by qRT-PCR analysis. Statistical signiﬁcance was determined
by one-way ANOVA. Error bar shows the standard error margin (SEM).
119M. Hoang et al. / Stem Cell Research 17 (2016) 111–121hypomethylation of speciﬁc genes have been shown to signiﬁcantly af-
fect NSCs' differentiation and proliferation. However, it is important to
note thatmany studies related to EtOHexposure and adult stem cell po-
tency have shown that the intrinsic genetic and epigenetic mechanisms
that control cellular fate are potentially of equal signiﬁcance.
The negative, long term effects of alcoholism on bone mass have
been well-established (Feskanich et al., 1999). Studies have shown
that heavy chronic alcohol consumption compromises bone quality
and increases the risk for osteoporosis. Other studies have shown thatalcoholism is associated with a variety of risk factors that may contrib-
ute to the pathogenesis of bone disease, including poor nutrition, liver
disease, malabsorption, vitamin D deﬁciency, hypogonadism, parathy-
roid dysfunction and tobacco use (Kim et al., 2003). Recent studies
have reported that alcoholmay affect bone formation through osteocyte
apoptosis, oxidative stress, and Wnt signaling pathway modulation
(Maurel et al., 2012). One study involving alcohol-binged rats suggested
that following administration of 20% alcohol/saline solution for 1, 2 or
3 weeks, a stimulation of bone resorption and decrease in bonemineral
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rent administration of risedronate, a bisphosphonate, mitigated the re-
sponse and maintained trabecular architectural indices (Callaci et al.,
2009). The duration of alcohol treatment resulted in the modulation of
expression proﬁles of RANKL and OPG, genes that regulate osteoclasto-
genesis. This study sheds light on the deleterious effects of bonemetab-
olism in response to binge drinking. However, the exact mechanisms of
how alcohol is related to bone loss remains unknown, but may include
both direct and indirect actions, and be related to diet and other lifestyle
factors.
While chronic alcohol abuse has been linked to an increase in the
risk for osteoporosis, light to moderate consumption has been correlat-
ed with a reduction in osteoporotic risk. Some studies have identiﬁed
that light to moderate concentrations of EtOH exposure has resulted
in higher bone mineral density and a reduced risk of osteoporosis
(Feskanich et al., 1999; Jugdaohsingh et al., 2006). Another study
found that light alcohol consumption resulted in increased lumbar
spine bone mineral density (BMD) and whole body BMD in postmeno-
pausal women (Ilich et al., 2002). In animal studies, low alcohol con-
sumption of ethanol (5%, 2 h per day) in 4-week old rats showed
higher BMD and greater trabecular thickness than compared to the con-
trol groups (Yamamoto et al., 1997). However, there are few animal
models related to the effects of light alcohol consumption in the litera-
ture and further investigative studies in animal models should be per-
formed in the future to shed light on these results. In contrast, at
longer durations of moderate to high alcoholic exposure, there is a
dose dependent effect on bone to increase risk for stress fractures. In a
rat study investigating the long-term effects of heavy alcohol consump-
tion on cancellous and cortical bone microarchitecture, ethanol con-
sumption resulted in lower bone mineral density and content,
reduced cortical thickness, and a lower femur length as compared to
controls (Johnson et al., 2014). These results suggest that chronic,
heavy alcohol consumption results in a decrease in bone size, mass,
and density, and negatively alters cancellous bone microarchitecture
resulting in decreased skeletal integrity.
In this study, we have used DPSCs as amodel to examine the effect of
EtOH on themineralization process. Our ﬁndings show that EtOH treat-
ment resulted in altered mineralization in DPSCs. The dysregulation of
odontogenic/osteogenic differentiation in DPSCs treated with EtOH is
reminiscent of previous ﬁndingswith reductions in bonemineral densi-
ty and volume.We discovered that EtOH treatment results in the reduc-
tion of several known mineralization-related gene expression proﬁles,
including ALP, BMP2, BMP4, DLX2, OCN, and OPN. These ﬁndings appear
to mirror potential biological mechanisms that are signiﬁcantly dysreg-
ulated in the etiology of alcohol-induced osteoporotic events. In vitro
studies are often difﬁcult to adapt to in vivo studies due to their inability
to fully simulate in vivo conditions. There are no in vitromodels to study
the effects of EtOH on bone formation and resorption (Turner, 2000).
Furthermore, one study identiﬁed a signiﬁcant discrepancy in body
weight gain and bone measurements due to the delivery method of
EtOH. In this study, intraperitoneal injection resulted in reduced body
weight, suppression of periosteal and cancellous bone formation, and
decreased mRNA levels for bone matrix proteins as compared to
intragastric administration (Iwaniec and Turner, 2013). This study sug-
gests that treatment of DPSCs in vitro using EtOH-containingmediamay
provide a dosage that is not replicable physiologically. In addition, the
effects of alcohol on epigenetic modiﬁers and bone loss may not be
fully adaptable to human studies, as it fails to take into account co-mor-
bidity factors including poor nutrition, vitamin deﬁciencies, mechanical
loading,weight and smoking (Turner, 2000). The effects of alcohol relat-
ed bone loss is controversial, with human studies reporting bone loss as
well as no bone loss.
Based on our ﬁndings on genome-wide, epigenetic effects of EtOH
on DPSCs, we analyzed known epigenetic modiﬁers to elucidate a po-
tential epigenetic link between alcohol and osteoporosis. Consistent
with our conclusion, KDM6B, a known epigenetic modiﬁer involved inosteogenic and odontogenic differentiation,was found to be signiﬁcant-
ly dysregulated in response to EtOH. Knockdown of KDM6B resulted in a
similar phenotype as EtOH treatment in vitrowhile concurrently show-
ing similar reductions in the gene expression proﬁles of known
osteomarkers. Thus, it is suggested that dysregulation of KDM6B by
EtOH reduces odontogenic/osteogenic potency of DPSCs, however the
molecular pathways behind the interactions of KDM6B and knownmin-
eralization-associated markers remain to be discovered.
Recent studies show that KDM6B is involved in the control of calci-
um-induced differentiation (Sen et al., 2008), regulates osteoblast dif-
ferentiation (Yang et al., 2013), and contributes to neuronal survival
and differentiation (Wijayatunge et al., 2014), odontogenic differentia-
tion of DPSCs (Xu et al., 2013), and osteogenic differentiation of
human BMSCs (Ye et al., 2012). It has been reported that calcium-in-
duced differentiation leads to increased binding of KDM6B and erasure
of repressive marks such as H3K27me3 (Sen et al., 2008). It has been
demonstrated that BMP4/7-mediated activation of SMAD1/4 may in-
duce the expression of KDM6B and trigger the osteogenic pathway (Ye
et al., 2012). Mechanistically, KDM6B is recruited to bone morphogenic
protein 2 (BMP2) and HOX (homeotic genes) promoters and activate
the odontogenic differentiation-related gene expression (Ye et al.,
2012). KDM6B removes epigenetic marks such as H3K27me3, from
the promoter of osteogenic genes to promote osteogenic commitment
(Ye et al., 2012). In addition, a recent study has demonstrated the facil-
itating role of KDM6B on odontogenic differentiation (Xu et al., 2013). It
needs to be experimentally demonstrated if EtOH triggers dysregulation
of KDM6B via altered regulation of differentiation signal-induced activa-
tion of the SMAD1/4 pathway and the control of theH3K27me3mark as
demonstrated in BMSCs (Ye et al., 2012).
In conclusion, our ﬁndings conﬁrmed that EtOH has a signiﬁcant im-
pact on the dysregulation of KDM6B and provides a potential epigenetic
effect of heavy alcohol exposure in DPSCs. These ﬁndings will be helpful
in identifying molecular mechanisms associated with alcohol induced
osteoporosis in a proper model, as it suggests a potential mechanism
of EtOH-induced suppression of mineralization. Further study is needed
to evaluate the signiﬁcance of our ﬁndings in fetal development where
maternal alcohol consumption results in craniofacial and dental abnor-
malities,which are hallmark features of fetal alcohol spectrumdisorders
(FASD).
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.05.021.
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